Today: 29 June 2026
Browse Category

NASDAQ:VSEE 21 October 2025 - 4 November 2025

Telehealth Trailblazer VSee Health (VSEE) Skyrockets on Game-Changing Deals & Federal Green Light

Telehealth Trailblazer VSee Health (VSEE) Skyrockets on Game-Changing Deals & Federal Green Light

VSee Health secured a three-year contract to deploy virtual urgent care at over 100 facilities for a major U.S. academic health system, starting January 2026. On Oct. 28, 2025, its telehealth platform received FedRAMP High Authorization, enabling federal agency use. Shares surged from $0.45 to over $1.00 after the news. Q2 2025 revenue nearly doubled to $3.4 million, but the company remains unprofitable.
VSee Health (VSEE) Stock Skyrockets 75% on $10M Hospital Teleradiology Contract

VSee Health (VSEE) Stock Skyrockets 75% on $10M Hospital Teleradiology Contract

VSee Health shares jumped 94% to $0.945 on Oct. 21 after announcing a multi-year teleradiology contract with a major Level-1 trauma hospital system, expected to generate $10 million over two years. Q2 2025 revenue nearly doubled year-over-year to $3.4 million, driven by the iDoc Telehealth acquisition. Analyst ratings remain bullish, with targets as high as $5. Volatility persists as VSEE trades below $1.
22 October 2025
VSee Health (VSEE) Stock Rockets 75% on $10M Hospital Teleradiology Deal – Is This Telehealth’s Next Big Winner?

VSee Health (VSEE) Stock Rockets 75% on $10M Hospital Teleradiology Deal – Is This Telehealth’s Next Big Winner?

VSee Health shares jumped 75% on Oct. 21 after announcing a multi-year teleradiology contract worth over $10 million with a leading Level 1 trauma hospital system. Trading volume surged to 226 million shares. The deal is expected to double VSee’s annual recurring revenue, with potential for an additional $5 million if targets are met. VSee recently secured a Nasdaq extension to resolve late filings.
21 October 2025

Stock Market Today

  • Top 10 Most Shorted ASX Stocks and Weekly Market Movers
    June 28, 2026, 11:00 PM EDT. The latest Short Seller Series highlights the 10 most heavily shorted stocks on the Australian Securities Exchange (ASX). This report also tracks significant weekly shifts in short interest, indicating which stocks are attracting more or less bearish bets. Investors often study short interest as it reflects market sentiment, showing which shares traders expect to fall. This update provides insight into the biggest risers and fallers in short positions, helping investors gauge potential market moves and emerging risks.

Latest articles

Trump-era loan caps could open door for private lenders in grad school market

Trump-era loan caps could open door for private lenders in grad school market

29 June 2026
July 1 federal loan caps slash Grad PLUS access, forcing many graduate and professional students to seek private loans; Sallie Mae projects up to 70% origination growth over several years, while SoFi reports record student-loan volume—investors now face a real-time test of how much demand shifts to private lenders as federal limits hit.
IREN Limited (NASDAQ:IREN) slides as Warriors badge faces AI revenue test

IREN Limited (NASDAQ:IREN) slides as Warriors badge faces AI revenue test

29 June 2026
IREN Limited (NASDAQ:IREN) plunged 21.3% to $47.21 over five straight down days despite announcing a record $50M+ annual Warriors jersey deal, as investors focused on the company’s not fully contracted $4.4B target ARR and high short interest at 19.74% of float, with Friday’s close near the lowest analyst target.
Go toTop